SRRKScholar Rock Holding Corporation

$4B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M

Gross Profit

-$34M-164.6% margin

Operating Income

-$55M-266.2% margin

Net Income

-$51M-248.9% margin

EPS (Diluted)

$-1.80

Cash Flow

Operating Cash Flow

-$63M

Free Cash Flow

-$66M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$196M

Total Liabilities

$83M

Stockholders' Equity

$113M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$0	—
Gross Profit	-$34M	-$807,000	-4079.1%
Operating Income	-$55M	-$51M	-7.6%
Net Income	-$51M	-$49M	-3.4%

SRRK FY 2019 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena